Global Pregabalin API Market Research Report 2026(Status and Outlook)

June 2026 | 153 pages | ID: G662BF7E73E5EN
Bosson Research

Abstracts

The global Pregabalin API market size was estimated at USD 500.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.00% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Pregabalin API market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Pregabalin API market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Pregabalin API market.

Global Pregabalin API Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

• SUANFARMA
• VASUDHA PHARMA
• Atom Pharma
• Sienna Biotec
• Kopran
• Teva
• Afton Pharma
• Cadila
• Sunshine Pharmaceutical
• Hanmi Fine Chemical
• Rivocean Jiangsu Pharmaceutical
• Hubei Vanz Pharm
• Menovo
• Saintsun
• SyncoZymes
• Taian Aidi Biotechnology

Market Segmentation (by Type)

• Purity ?99%
• Purity ?99.5%

Market Segmentation (by Application)

• Tablet
• Capsule
• Oral Liquid

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Pregabalin API Market

Overview of the regional outlook of the Pregabalin API Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pregabalin API Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Pregabalin API, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Pregabalin API
1.2 Key Market Segments
  1.2.1 Pregabalin API Segment by Type
  1.2.2 Pregabalin API Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 PREGABALIN API MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Pregabalin API Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Pregabalin API Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 PREGABALIN API MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Pregabalin API Product Life Cycle
3.3 Global Pregabalin API Sales by Manufacturers (2020-2025)
3.4 Global Pregabalin API Revenue Market Share by Manufacturers (2020-2025)
3.5 Pregabalin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Pregabalin API Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Pregabalin API Market Competitive Situation and Trends
  3.8.1 Pregabalin API Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Pregabalin API Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 PREGABALIN API INDUSTRY CHAIN ANALYSIS

4.1 Pregabalin API Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF PREGABALIN API MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Pregabalin API Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy – April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Pregabalin API Market
5.7 ESG Ratings of Leading Companies

6 PREGABALIN API MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pregabalin API Sales Market Share by Type (2020-2025)
6.3 Global Pregabalin API Market Size by Type (2020-2025)
6.4 Global Pregabalin API Price by Type (2020-2025)

7 PREGABALIN API MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pregabalin API Market Sales by Application (2020-2025)
7.3 Global Pregabalin API Market Size (M USD) by Application (2020-2025)
7.4 Global Pregabalin API Sales Growth Rate by Application (2020-2025)

8 PREGABALIN API MARKET SALES BY REGION

8.1 Global Pregabalin API Sales by Region
  8.1.1 Global Pregabalin API Sales by Region
  8.1.2 Global Pregabalin API Sales Market Share by Region
8.2 Global Pregabalin API Market Size by Region
  8.2.1 Global Pregabalin API Market Size by Region
  8.2.2 Global Pregabalin API Market Size by Region
8.3 North America
  8.3.1 North America Pregabalin API Sales by Country
  8.3.2 North America Pregabalin API Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Pregabalin API Sales by Country
  8.4.2 Europe Pregabalin API Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Pregabalin API Sales by Region
  8.5.2 Asia Pacific Pregabalin API Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Pregabalin API Sales by Country
  8.6.2 South America Pregabalin API Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Pregabalin API Sales by Region
  8.7.2 Middle East and Africa Pregabalin API Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 PREGABALIN API MARKET PRODUCTION BY REGION

9.1 Global Production of Pregabalin API by Region(2020-2025)
9.2 Global Pregabalin API Revenue Market Share by Region (2020-2025)
9.3 Global Pregabalin API Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Pregabalin API Production
  9.4.1 North America Pregabalin API Production Growth Rate (2020-2025)
  9.4.2 North America Pregabalin API Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Pregabalin API Production
  9.5.1 Europe Pregabalin API Production Growth Rate (2020-2025)
  9.5.2 Europe Pregabalin API Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Pregabalin API Production (2020-2025)
  9.6.1 Japan Pregabalin API Production Growth Rate (2020-2025)
  9.6.2 Japan Pregabalin API Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Pregabalin API Production (2020-2025)
  9.7.1 China Pregabalin API Production Growth Rate (2020-2025)
  9.7.2 China Pregabalin API Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 SUANFARMA
  10.1.1 SUANFARMA Basic Information
  10.1.2 SUANFARMA Pregabalin API Product Overview
  10.1.3 SUANFARMA Pregabalin API Product Market Performance
  10.1.4 SUANFARMA Business Overview
  10.1.5 SUANFARMA SWOT Analysis
  10.1.6 SUANFARMA Recent Developments
10.2 VASUDHA PHARMA
  10.2.1 VASUDHA PHARMA Basic Information
  10.2.2 VASUDHA PHARMA Pregabalin API Product Overview
  10.2.3 VASUDHA PHARMA Pregabalin API Product Market Performance
  10.2.4 VASUDHA PHARMA Business Overview
  10.2.5 VASUDHA PHARMA SWOT Analysis
  10.2.6 VASUDHA PHARMA Recent Developments
10.3 Atom Pharma
  10.3.1 Atom Pharma Basic Information
  10.3.2 Atom Pharma Pregabalin API Product Overview
  10.3.3 Atom Pharma Pregabalin API Product Market Performance
  10.3.4 Atom Pharma Business Overview
  10.3.5 Atom Pharma SWOT Analysis
  10.3.6 Atom Pharma Recent Developments
10.4 Sienna Biotec
  10.4.1 Sienna Biotec Basic Information
  10.4.2 Sienna Biotec Pregabalin API Product Overview
  10.4.3 Sienna Biotec Pregabalin API Product Market Performance
  10.4.4 Sienna Biotec Business Overview
  10.4.5 Sienna Biotec Recent Developments
10.5 Kopran
  10.5.1 Kopran Basic Information
  10.5.2 Kopran Pregabalin API Product Overview
  10.5.3 Kopran Pregabalin API Product Market Performance
  10.5.4 Kopran Business Overview
  10.5.5 Kopran Recent Developments
10.6 Teva
  10.6.1 Teva Basic Information
  10.6.2 Teva Pregabalin API Product Overview
  10.6.3 Teva Pregabalin API Product Market Performance
  10.6.4 Teva Business Overview
  10.6.5 Teva Recent Developments
10.7 Afton Pharma
  10.7.1 Afton Pharma Basic Information
  10.7.2 Afton Pharma Pregabalin API Product Overview
  10.7.3 Afton Pharma Pregabalin API Product Market Performance
  10.7.4 Afton Pharma Business Overview
  10.7.5 Afton Pharma Recent Developments
10.8 Cadila
  10.8.1 Cadila Basic Information
  10.8.2 Cadila Pregabalin API Product Overview
  10.8.3 Cadila Pregabalin API Product Market Performance
  10.8.4 Cadila Business Overview
  10.8.5 Cadila Recent Developments
10.9 Sunshine Pharmaceutical
  10.9.1 Sunshine Pharmaceutical Basic Information
  10.9.2 Sunshine Pharmaceutical Pregabalin API Product Overview
  10.9.3 Sunshine Pharmaceutical Pregabalin API Product Market Performance
  10.9.4 Sunshine Pharmaceutical Business Overview
  10.9.5 Sunshine Pharmaceutical Recent Developments
10.10 Hanmi Fine Chemical
  10.10.1 Hanmi Fine Chemical Basic Information
  10.10.2 Hanmi Fine Chemical Pregabalin API Product Overview
  10.10.3 Hanmi Fine Chemical Pregabalin API Product Market Performance
  10.10.4 Hanmi Fine Chemical Business Overview
  10.10.5 Hanmi Fine Chemical Recent Developments
10.11 Rivocean Jiangsu Pharmaceutical
  10.11.1 Rivocean Jiangsu Pharmaceutical Basic Information
  10.11.2 Rivocean Jiangsu Pharmaceutical Pregabalin API Product Overview
  10.11.3 Rivocean Jiangsu Pharmaceutical Pregabalin API Product Market Performance
  10.11.4 Rivocean Jiangsu Pharmaceutical Business Overview
  10.11.5 Rivocean Jiangsu Pharmaceutical Recent Developments
10.12 Hubei Vanz Pharm
  10.12.1 Hubei Vanz Pharm Basic Information
  10.12.2 Hubei Vanz Pharm Pregabalin API Product Overview
  10.12.3 Hubei Vanz Pharm Pregabalin API Product Market Performance
  10.12.4 Hubei Vanz Pharm Business Overview
  10.12.5 Hubei Vanz Pharm Recent Developments
10.13 Menovo
  10.13.1 Menovo Basic Information
  10.13.2 Menovo Pregabalin API Product Overview
  10.13.3 Menovo Pregabalin API Product Market Performance
  10.13.4 Menovo Business Overview
  10.13.5 Menovo Recent Developments
10.14 Saintsun
  10.14.1 Saintsun Basic Information
  10.14.2 Saintsun Pregabalin API Product Overview
  10.14.3 Saintsun Pregabalin API Product Market Performance
  10.14.4 Saintsun Business Overview
  10.14.5 Saintsun Recent Developments
10.15 SyncoZymes
  10.15.1 SyncoZymes Basic Information
  10.15.2 SyncoZymes Pregabalin API Product Overview
  10.15.3 SyncoZymes Pregabalin API Product Market Performance
  10.15.4 SyncoZymes Business Overview
  10.15.5 SyncoZymes Recent Developments
10.16 Taian Aidi Biotechnology
  10.16.1 Taian Aidi Biotechnology Basic Information
  10.16.2 Taian Aidi Biotechnology Pregabalin API Product Overview
  10.16.3 Taian Aidi Biotechnology Pregabalin API Product Market Performance
  10.16.4 Taian Aidi Biotechnology Business Overview
  10.16.5 Taian Aidi Biotechnology Recent Developments

11 PREGABALIN API MARKET FORECAST BY REGION

11.1 Global Pregabalin API Market Size Forecast
11.2 Global Pregabalin API Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Pregabalin API Market Size Forecast by Country
  11.2.3 Asia Pacific Pregabalin API Market Size Forecast by Region
  11.2.4 South America Pregabalin API Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Pregabalin API by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Pregabalin API Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Pregabalin API by Type (2026-2035)
  12.1.2 Global Pregabalin API Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Pregabalin API by Type (2026-2035)
12.2 Global Pregabalin API Market Forecast by Application (2026-2035)
  12.2.1 Global Pregabalin API Sales (K MT) Forecast by Application
  12.2.2 Global Pregabalin API Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Pregabalin API Market Size by Type (M USD)
Table 4. Global Pregabalin API Market Size by Application
Table 5. Pregabalin API Market Size Comparison by Region (M USD)
Table 6. Global Pregabalin API Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Pregabalin API Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Pregabalin API Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Pregabalin API Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pregabalin API as of 2025)
Table 11. Global Market Pregabalin API Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Pregabalin API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pregabalin API Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Pregabalin API Sales by Type (K MT)
Table 27. Global Pregabalin API Market Size by Type (M USD)
Table 28. Global Pregabalin API Sales (K MT) by Type (2020-2025)
Table 29. Global Pregabalin API Sales Market Share by Type (2020-2025)
Table 30. Global Pregabalin API Market Size (M USD) by Type (2020-2025)
Table 31. Global Pregabalin API Market Share by Type (2020-2025)
Table 32. Global Pregabalin API Price (USD/KG) by Type (2020-2025)
Table 33. Global Pregabalin API Sales (K MT) by Application
Table 34. Global Pregabalin API Market Size by Application
Table 35. Global Pregabalin API Sales by Application (2020-2025) & (K MT)
Table 36. Global Pregabalin API Sales Market Share by Application (2020-2025)
Table 37. Global Pregabalin API Market Size by Application (2020-2025) & (M USD)
Table 38. Global Pregabalin API Market Share by Application (2020-2025)
Table 39. Global Pregabalin API Sales Growth Rate by Application (2020-2025)
Table 40. Global Pregabalin API Sales by Region (2020-2025) & (K MT)
Table 41. Global Pregabalin API Sales Market Share by Region (2020-2025)
Table 42. Global Pregabalin API Market Size by Region (2020-2025) & (M USD)
Table 43. Global Pregabalin API Market Size by Region (2020-2025)
Table 44. North America Pregabalin API Sales by Country (2020-2025) & (K MT)
Table 45. North America Pregabalin API Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Pregabalin API Sales by Country (2020-2025) & (K MT)
Table 47. Europe Pregabalin API Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Pregabalin API Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Pregabalin API Market Size by Region (2020-2025) & (M USD)
Table 50. South America Pregabalin API Sales by Country (2020-2025) & (K MT)
Table 51. South America Pregabalin API Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Pregabalin API Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Pregabalin API Market Size by Region (2020-2025) & (M USD)
Table 54. Global Pregabalin API Production (K MT) by Region(2020-2025)
Table 55. Global Pregabalin API Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Pregabalin API Revenue Market Share by Region (2020-2025)
Table 57. Global Pregabalin API Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Pregabalin API Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Pregabalin API Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Pregabalin API Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Pregabalin API Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. SUANFARMA Basic Information
Table 63. SUANFARMA Pregabalin API Product Overview
Table 64. SUANFARMA Pregabalin API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. SUANFARMA Business Overview
Table 66. SUANFARMA SWOT Analysis
Table 67. SUANFARMA Recent Developments
Table 68. VASUDHA PHARMA Basic Information
Table 69. VASUDHA PHARMA Pregabalin API Product Overview
Table 70. VASUDHA PHARMA Pregabalin API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. VASUDHA PHARMA Business Overview
Table 72. VASUDHA PHARMA SWOT Analysis
Table 73. VASUDHA PHARMA Recent Developments
Table 74. Atom Pharma Basic Information
Table 75. Atom Pharma Pregabalin API Product Overview
Table 76. Atom Pharma Pregabalin API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Atom Pharma Business Overview
Table 78. Atom Pharma SWOT Analysis
Table 79. Atom Pharma Recent Developments
Table 80. Sienna Biotec Basic Information
Table 81. Sienna Biotec Pregabalin API Product Overview
Table 82. Sienna Biotec Pregabalin API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Sienna Biotec Business Overview
Table 84. Sienna Biotec Recent Developments
Table 85. Kopran Basic Information
Table 86. Kopran Pregabalin API Product Overview
Table 87. Kopran Pregabalin API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Kopran Business Overview
Table 89. Kopran Recent Developments
Table 90. Teva Basic Information
Table 91. Teva Pregabalin API Product Overview
Table 92. Teva Pregabalin API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Teva Business Overview
Table 94. Teva Recent Developments
Table 95. Afton Pharma Basic Information
Table 96. Afton Pharma Pregabalin API Product Overview
Table 97. Afton Pharma Pregabalin API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Afton Pharma Business Overview
Table 99. Afton Pharma Recent Developments
Table 100. Cadila Basic Information
Table 101. Cadila Pregabalin API Product Overview
Table 102. Cadila Pregabalin API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Cadila Business Overview
Table 104. Cadila Recent Developments
Table 105. Sunshine Pharmaceutical Basic Information
Table 106. Sunshine Pharmaceutical Pregabalin API Product Overview
Table 107. Sunshine Pharmaceutical Pregabalin API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Sunshine Pharmaceutical Business Overview
Table 109. Sunshine Pharmaceutical Recent Developments
Table 110. Hanmi Fine Chemical Basic Information
Table 111. Hanmi Fine Chemical Pregabalin API Product Overview
Table 112. Hanmi Fine Chemical Pregabalin API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Hanmi Fine Chemical Business Overview
Table 114. Hanmi Fine Chemical Recent Developments
Table 115. Rivocean Jiangsu Pharmaceutical Basic Information
Table 116. Rivocean Jiangsu Pharmaceutical Pregabalin API Product Overview
Table 117. Rivocean Jiangsu Pharmaceutical Pregabalin API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Rivocean Jiangsu Pharmaceutical Business Overview
Table 119. Rivocean Jiangsu Pharmaceutical Recent Developments
Table 120. Hubei Vanz Pharm Basic Information
Table 121. Hubei Vanz Pharm Pregabalin API Product Overview
Table 122. Hubei Vanz Pharm Pregabalin API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Hubei Vanz Pharm Business Overview
Table 124. Hubei Vanz Pharm Recent Developments
Table 125. Menovo Basic Information
Table 126. Menovo Pregabalin API Product Overview
Table 127. Menovo Pregabalin API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Menovo Business Overview
Table 129. Menovo Recent Developments
Table 130. Saintsun Basic Information
Table 131. Saintsun Pregabalin API Product Overview
Table 132. Saintsun Pregabalin API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Saintsun Business Overview
Table 134. Saintsun Recent Developments
Table 135. SyncoZymes Basic Information
Table 136. SyncoZymes Pregabalin API Product Overview
Table 137. SyncoZymes Pregabalin API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. SyncoZymes Business Overview
Table 139. SyncoZymes Recent Developments
Table 140. Taian Aidi Biotechnology Basic Information
Table 141. Taian Aidi Biotechnology Pregabalin API Product Overview
Table 142. Taian Aidi Biotechnology Pregabalin API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Taian Aidi Biotechnology Business Overview
Table 144. Taian Aidi Biotechnology Recent Developments
Table 145. Global Pregabalin API Sales Forecast by Region (2026-2035) & (K MT)
Table 146. Global Pregabalin API Market Size Forecast by Region (2026-2035) & (M USD)
Table 147. North America Pregabalin API Sales Forecast by Country (2026-2035) & (K MT)
Table 148. North America Pregabalin API Market Size Forecast by Country (2026-2035) & (M USD)
Table 149. Europe Pregabalin API Sales Forecast by Country (2026-2035) & (K MT)
Table 150. Europe Pregabalin API Market Size Forecast by Country (2026-2035) & (M USD)
Table 151. Asia Pacific Pregabalin API Sales Forecast by Region (2026-2035) & (K MT)
Table 152. Asia Pacific Pregabalin API Market Size Forecast by Region (2026-2035) & (M USD)
Table 153. South America Pregabalin API Sales Forecast by Country (2026-2035) & (K MT)
Table 154. South America Pregabalin API Market Size Forecast by Country (2026-2035) & (M USD)
Table 155. Middle East and Africa Pregabalin API Sales Forecast by Country (2026-2035) & (Units)
Table 156. Middle East and Africa Pregabalin API Market Size Forecast by Country (2026-2035) & (M USD)
Table 157. Global Pregabalin API Sales Forecast by Type (2026-2035) & (K MT)
Table 158. Global Pregabalin API Market Size Forecast by Type (2026-2035) & (M USD)
Table 159. Global Pregabalin API Price Forecast by Type (2026-2035) & (USD/KG)
Table 160. Global Pregabalin API Sales (K MT) Forecast by Application (2026-2035)
Table 161. Global Pregabalin API Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Pregabalin API
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pregabalin API Market Size (M USD), 2025-2035
Figure 5. Global Pregabalin API Market Size (M USD) (2020-2035)
Figure 6. Global Pregabalin API Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pregabalin API Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Pregabalin API Product Life Cycle
Figure 13. Pregabalin API Sales Share by Manufacturers in 2025
Figure 14. Global Pregabalin API Revenue Share by Manufacturers in 2025
Figure 15. Pregabalin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Pregabalin API Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Pregabalin API Revenue in 2025
Figure 18. Industry Chain Map of Pregabalin API
Figure 19. Global Pregabalin API Market PEST Analysis
Figure 20. Global Pregabalin API Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Pregabalin API Market Share by Type
Figure 27. Sales Market Share of Pregabalin API by Type (2020-2025)
Figure 28. Sales Market Share of Pregabalin API by Type in 2025
Figure 29. Market Share of Pregabalin API by Type (2020-2025)
Figure 30. Market Share of Pregabalin API by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Pregabalin API Market Share by Application
Figure 33. Global Pregabalin API Sales Market Share by Application (2020-2025)
Figure 34. Global Pregabalin API Sales Market Share by Application in 2025
Figure 35. Global Pregabalin API Market Share by Application (2020-2025)
Figure 36. Global Pregabalin API Market Share by Application in 2025
Figure 37. Global Pregabalin API Sales Growth Rate by Application (2020-2025)
Figure 38. Global Pregabalin API Sales Market Share by Region (2020-2025)
Figure 39. Global Pregabalin API Market Size by Region (2020-2025)
Figure 40. North America Pregabalin API Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Pregabalin API Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Pregabalin API Sales Market Share by Country in 2024
Figure 43. North America Pregabalin API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Pregabalin API Market Size by Country in 2024
Figure 45. U.S. Pregabalin API Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Pregabalin API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Pregabalin API Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Pregabalin API Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Pregabalin API Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Pregabalin API Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Pregabalin API Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Pregabalin API Sales Market Share by Country in 2024
Figure 53. Europe Pregabalin API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Pregabalin API Market Size by Country in 2024
Figure 55. Germany Pregabalin API Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Pregabalin API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Pregabalin API Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Pregabalin API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Pregabalin API Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Pregabalin API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Pregabalin API Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Pregabalin API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Pregabalin API Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Pregabalin API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Pregabalin API Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Pregabalin API Sales Market Share by Region in 2024
Figure 67. Asia Pacific Pregabalin API Market Size by Region in 2024
Figure 68. China Pregabalin API Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Pregabalin API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Pregabalin API Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Pregabalin API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Pregabalin API Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Pregabalin API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Pregabalin API Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Pregabalin API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Pregabalin API Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Pregabalin API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Pregabalin API Sales and Growth Rate (K MT)
Figure 79. South America Pregabalin API Sales Market Share by Country in 2024
Figure 80. South America Pregabalin API Market Size and Growth Rate (M USD)
Figure 81. South America Pregabalin API Market Size by Country in 2024
Figure 82. Brazil Pregabalin API Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Pregabalin API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Pregabalin API Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Pregabalin API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Pregabalin API Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Pregabalin API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Pregabalin API Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Pregabalin API Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Pregabalin API Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Pregabalin API Market Size by Region in 2024
Figure 92. Saudi Arabia Pregabalin API Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Pregabalin API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Pregabalin API Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Pregabalin API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Pregabalin API Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Pregabalin API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Pregabalin API Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Pregabalin API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Pregabalin API Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Pregabalin API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Pregabalin API Production Market Share by Region (2020-2025)
Figure 103. North America Pregabalin API Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Pregabalin API Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Pregabalin API Production (K MT) Growth Rate (2020-2025)
Figure 106. China Pregabalin API Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Pregabalin API Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Pregabalin API Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Pregabalin API Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Pregabalin API Market Share Forecast by Type (2026-2035)
Figure 111. Global Pregabalin API Sales Forecast by Application (2026-2035)
Figure 112. Global Pregabalin API Market Share Forecast by Application (2026-2035)